Edesa Biotech Inc is a biotechnology company focused in the field of dermatology and gastroenterology. It is involved in exploring ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis.
